# Nuclide record paper-kratochwil-ac225-psma-jnm-2016 (paper). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/key-papers/paper-kratochwil-ac225-psma-jnm-2016/>
  a schema:ScholarlyArticle ;
  nuclide:kind "paper" ;
  schema:identifier "paper-kratochwil-ac225-psma-jnm-2016" ;
  schema:name "225Ac-PSMA-617 for PSMA-targeted alpha-radiation therapy of metastatic castration-resistant prostate cancer"@en ;
  schema:description "The first published report of two men with very advanced prostate cancer, who had run out of other options, having their cancer disappear on scans after treatment with an alpha-emitting radioactive drug aimed at PSMA."@en ;
  schema:url <https://nuclide.cc/key-papers/paper-kratochwil-ac225-psma-jnm-2016/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://jnm.snmjournals.org/content/jnumed/57/12/1941.full.pdf>, <https://pubmed.ncbi.nlm.nih.gov/27389577/> ;
  nuclide:tag "alpha therapy", "prostate cancer", "first-in-human" ;
  schema:sameAs <https://doi.org/10.2967/jnumed.116.178673> ;
  schema:datePublished "2016"^^xsd:gYear ;
  schema:author "Kratochwil C, Bruchertseifer F, Giesel FL, Weis M, Verburg FA, et al." ;
  nuclide:related <https://nuclide.cc/drugs/ac225-psma/>, <https://nuclide.cc/technologies/targeted-alpha-therapy/>, <https://nuclide.cc/targets/psma/>, <https://nuclide.cc/indications/prostate-mcrpc/>, <https://nuclide.cc/people/clemens-kratochwil/>, <https://nuclide.cc/people/uwe-haberkorn/>, <https://nuclide.cc/pairings/beta-then-alpha/>, <https://nuclide.cc/isotopes/ga-68/>, <https://nuclide.cc/isotopes/lu-177/>, <https://nuclide.cc/isotopes/ac-225/> .